Robert W. Baird boosted their price objective on ResMed from $280.00 to $283.00 and gave the company an “outperform” rating in a research report on Friday, October 25th. Royal Bank of Canada lifted ...
Investment analysts at William Blair issued their Q2 2025 earnings per share estimates for shares of ResMed in a research ...
Shares of ResMed Inc. RMD inched 0.61% higher to $232.58 Tuesday, on what proved to be an all-around positive trading session ...
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...
Shares of ResMed Inc. RMD slipped 1.65% to $238.52 Friday, on what proved to be an all-around mixed trading session for the ...
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results